Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0316681 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Aditya K Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Onychomycosis, Healthcare Disparities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Onychomycosis is a common, difficult to treat nail disorder. Our objective was to explore disparities in current clinical management practices for onychomycosis in patients from underrepresented groups and with specific comorbidities. We conducted a cross-sectional study using the All of Us (AoU) research program. The AoU program gathers survey, and electronic health records from participants in the United States with the aim of increasing the representation of minorities groups in health research under the framework of precision medicine. We identified 18,763 onychomycosis patients (2017–2022) and compared the rates of diagnostic testing, prescription medications and surgical procedures. Younger patients were more likely to receive oral medications, while older patients were more likely to undergo surgical nail procedures. Patients with lower income and education, Black and Hispanic patients were less likely to receive testing to confirm diagnosis, and less likely to receive prescription medications (topical and/or oral) except in the case of fluconazole. Lower income and education were associated with a higher likelihood of debridement and trimming procedures, while Black and Hispanic patients were less likely to undergo these procedures. Patients with disabilities also received different treatments when compared to able-bodied individuals, being less likely to receive ciclopirox, efinaconazole and terbinafine, but more likely to undergo debridement and trimming procedures. There are clear differences in the management of onychomycosis in the different demographic and comorbid populations that we studied. Efforts to reduce these inequalities, such as expanded health coverage, reducing communication barriers and increasing patient and physician education are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Mediprobe Research Inc., London, Ontario, Canada.
- Department of Medical Biophysics, Schulich Scholl of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
- Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
ORCID-Profile: Aditya K Gupta
Zitieren
APA
Gupta, A. K., Economopoulos, V., Wang, T., & Piguet, V. (2025). Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program. PLOS ONE. https://doi.org/10.1371/journal.pone.0316681
Vancouver
Gupta AK, Economopoulos V, Wang T, Piguet V. Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program. PLOS ONE. 2025. doi:10.1371/journal.pone.0316681
BibTeX
@article{Gupta2025,
author = {Gupta, Aditya K and Economopoulos, Vasiliki and Wang, Tong and Piguet, Vincent},
title = {Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0316681}
}
EUVIMED